MyFinsight
Home
Blog
About
Proceeds from sales of
marketable securities
$5,250K
(-9.50%↓ Y/Y)
Issuance of common stock
and warrants, net
$16K
(-99.95%↓ Y/Y)
Net cash flows
provided by (used in)...
$4,471K
(117.10%↑ Y/Y)
Net cash flows
provided by financing...
$16K
(-99.95%↓ Y/Y)
Canceled cashflow
$779K
Increase (decrease) in
cash, cash...
-$502K
(-151.65%↓ Y/Y)
Canceled cashflow
$4,487K
Other payables and
accrued liabilities
$835K
(807.61%↑ Y/Y)
Share-based compensation
$433K
(-12.17%↓ Y/Y)
Prepaid expenses and
other assets
-$69K
(57.14%↑ Y/Y)
Depreciation of property and
equipment
$15K
(-44.44%↓ Y/Y)
Interest income and
unrealized gains from...
-$7K
(-105.88%↓ Y/Y)
Purchases of marketable
securities
$629K
(-98.03%↓ Y/Y)
Purchases of property and
equipment
$142K
(545.45%↑ Y/Y)
Increase in restricted
deposit
$8K
Net cash flows used
in operating...
-$4,989K
(8.41%↑ Y/Y)
Canceled cashflow
$1,359K
Net loss
-$5,627K
(7.77%↑ Y/Y)
Inventory
$650K
Accounts receivable
$71K
Back
Back
Cash Flow
Microbot Medical Inc. (MBOT)
Microbot Medical Inc. (MBOT)
source: myfinsight.com